Shire adding in-house Cinryze production after shortage, but continues to shed plants

30th October 2017 Uncategorised 0

Shire intends to take some manufacturing of its rare disease drug Cinryze in house after problems with a contractor led to a shortage of the drug. The move comes even as Shire has targeted three more plants for elimination in its efforts to pare down its production network after picking up a bunch of plants in its buyout of Baxalta.

More: Shire adding in-house Cinryze production after shortage, but continues to shed plants
Source: fierce